Precigenetics is a biotechnology company revolutionizing drug discovery by providing real-time insights into epigenetic changes, thereby eliminating guesswork in precision medicine and targeted therapies. Their proprietary platform, COMPASS, enables real-time single-cell analysis of epigenetic mechanisms, offering unprecedented understanding of how cells regulate and adapt in response to diseases and treatments. Key Features and Functionality: - Real-time Analysis: Facilitates immediate observation of epigenetic changes at the single-cell level. - Non-destructive Insights: Preserves cell integrity while providing comprehensive biological data. - Accelerated Discovery: Shortens discovery timelines by delivering immediate biological feedback. - High-throughput Scale: Effectively scales for extensive applications and screening processes. Primary Value and Problem Solved: By directly visualizing epigenetic changes without harming cells, Precigenetics empowers researchers and clinicians to address diseases with greater accuracy and efficiency. This approach is particularly transformative in precision oncology, where understanding individual cell behaviors and disease pathways is crucial for developing targeted therapies. The COMPASS platform's real-time, non-destructive analysis accelerates the identification of effective treatments, overcoming the limitations of traditional drug discovery methods that often rely on static snapshots and indirect evidence.